InfantRisk HCP vs Contraception

Pregnant and breastfeeding patients deserve safe, effective care. Too often, treatment decisions are clouded by uncertainty. InfantRisk HCP gives healthcare professionals fast, evidence-based guidance on medication safety in pregnancy and lactation—so you can make confident choices in seconds. Developed by leading researchers and clinicians, the app provides: • Quick drug safety ratings (1 = safest, 5 = most hazardous) for pregnancy and breastfeeding • Access to over 70,000 medications with concise, evidence-based summaries • Easy comparison of safety ratings by indication or drug class • A clean, intuitive interface with monthly data updates Are you a parent? Try our companion app, MommyMeds, written with patients in mind. Subscription: $14.99 USD per year Terms of Use: https://www.infantrisk.com/infantrisk-hcp-terms-use Disclaimer: The information in InfantRisk HCP is designed to support—not replace—clinical judgment and individualized patient care.

The U.S. Medical Eligibility Criteria for Contraceptive Use comprises recommendations for the use of specific contraceptive methods by patients who have certain characteristics or medical conditions. The U.S. Selected Practice Recommendations for Contraceptive Use addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. The app is developed directly from the CDC Morbidity and Mortality Weekly Report (MMWR) by the Division of Reproductive Health and covers more than 60 characteristics or medical conditions (U.S. MEC) and numerous clinical situations (U.S. SPR). These recommendations are intended to assist healthcare providers when they counsel women, men, and couples about contraceptive method choice and use. Although these recommendations are meant to serve as a source or clinical guidance, healthcare providers should always consider the individual clinical circumstances of each person seeking family planning services.